• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

richard.birkinshaw@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
Department of Medical Biology (WEHI)
ORCID

0000-0003-1825-0182

Dr Richard Birkinshaw

Honorary (Fellow)
Department of Medical Biology (WEHI)

49 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    The E3-ome gene-centric compendium reveals the human E3 ligase landscape
    DOI: 10.1016/j.cell.2026.01.029
  • 2026

    Journal article

    MK-7602: a potent multi-stage dual-targeting antimalarial
    DOI: 10.1016/j.ebiom.2025.106061
  • 2025

    Journal article

    Computational design of potent and selective binders of BAK and BAX
    DOI: 10.1126/sciadv.adt4170
  • 2020

    Journal article

    Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
    DOI: 10.1182/BLOOD.2019004205
  • 2019

    Journal article

    Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
    DOI: 10.1038/s41467-019-10363-1
  • 2019

    Journal article

    Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
    DOI: 10.1111/bjh.16069
  • 2019

    Journal article

    Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia
    DOI: 10.1158/2159-8290.CD-18-1119
Richard Birkinshaw

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice
    DOI: 10.1038/s41375-025-02662-y
  • 2025

    Journal article

    Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
    DOI: 10.1126/sciadv.adr8146
  • 2025

    Journal article

    Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia
    DOI: 10.1182/bloodadvances.2024014446
  • 2025

    Journal article

    A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
    DOI: 10.1038/s41467-025-57905-4
  • 2024

    Journal article

    Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis
    DOI: 10.1371/journal.pbio.3002617
  • 2023

    Journal article

    The crystal structure of detergent-activated BAK dimers provides insights into BAK activation steps and how they stabilise membrane pores
    DOI: 10.1107/s205327332308912x
  • 2022

    Journal article

    Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation
    DOI: 10.1038/s41418-022-00961-w

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224